Scientists investigate why skin fails to heal in rare blistering disease
NCT ID NCT01874769
First seen Mar 21, 2026 · Last updated Jun 08, 2026 · Updated 11 times
Summary
This study looked at how skin cells from 30 people with recessive dystrophic epidermolysis bullosa (RDEB) grow and repair wounds. RDEB is a rare genetic condition that causes fragile skin and painful blisters. Researchers took small skin samples to study the cells in a lab, aiming to better understand the disease. No new treatment was tested; the goal was to gather knowledge for future therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Guy's and ST Thomas NHS Foundation trust/Guy's Hospital
London, SE19RT, United Kingdom
-
Inserm U781 Service de Génétique Necker Hospital for sick children
Paris, 75743/ Cedex 15, France
-
Service de dermatologie Necker Hospital for sick children
Paris, 75743 Cedex 15, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.